Eloxx Pharmaceuticals Reports Second Quarter 2022 Financial and Operating Results and Provides Business Update

Go back to Eloxx Pharmaceuticals Reports Second Quarter 2022 Financial and Operating Results and Provides Business Update
(NASDAQ: ELOX) Delayed: 13.74 --0 (-0%)
Previous Close $13.74    52 Week High $ 
Open $13.74    52 Week Low $ 
Day High $13.74    P/E N/A 
Day Low $13.74    EPS $ 
Volume 3,278